DR. THO LYE MUN
MBBS(Sydney), MRCP(UK), FRCR(UK), PhD(Glasgow), CCT in Clinical Oncology(UK), Fellowship in Molecular Oncology(UK)
Dr. Tho Lye Mun read Medicine as a John Crawford Scholar and graduated from the University of Sydney, Australia in 1998. He went on to train and work in the UK, obtaining both internal medicine MRCP (UK) and clinical oncology FRCR (UK) qualifications. He was then awarded a prestigious joint Cancer Research UK and Royal College of Radiologists research fellowship where his research into novel checkpoint inhibitors as anti-cancer therapy led to him being awarded a PhD in molecular oncology from the University of Glasgow.
For his work he was also awarded the John Paul Medal and Anne Hollman Medal. After training and working overseas for 23 years, Dr. Tho returned to Malaysia taking up the post of Associate Professor at the University of Malaya and he then subsequently moved into private practice. His passion and commitment to lung cancer has seen him lead many clinical studies in the field, in particular immunotherapy and serve on numerous regional and international advisory bodies and guideline committees.
He has also pioneered the use of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) for lung cancer having undergone further training in Korea and the Cleveland Clinic, USA. He is the current Vice President of South East Asian Radiation Oncology Group (SEAROG). He is co-founder and Vice President of Lung Cancer Network Malaysia.